ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,369, issued on Aug. 26, was assigned to BEIJING IMMUTECH LLC (Beijing).

"Purified double negative T cell and preparation and use thereof" was invented by Dong Zhang (Beijing), Yanbing Zhu (Beijing), Lu Yang (Beijing), Dan Tian (Beijing), Song Wang (Beijing) and Guangyong Sun (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a DNT cell population with IL-17 secretory cells removed and a preparation method therefor and the use thereof. The DNT cell population has the effects of inhibiting T cell proliferation and inducing apoptosis, can inhibit the inflammation of adipose tissue, improve insulin resistance, alleviate diabetes, and re...